Recently, Shih et al. characterized the genomic landscape of BrMs from 73 patients with lung adenocarcinoma via WES, and discovered increases in amplification frequencies of MYC, YAP1, and MMP13 [11]. This evidence concerns the gene MMP13 and lung adenocarcinoma.